// App-Quantinova.ai

2846 : Clinical Utility of PRV-1 mRNA Expression Levels in Polycythemia Vera and Essential Thrombocythemia.

Researchers

Presenter

  • Yu-Shin Hung

Principal Investigators

  • Chia-Hui Chang

  • Lee-Yung Shih

  • Yu-Hui Huang

  • Tung-Liang Lin

  • Tung-Huei Lin

  • Po Dunn

  • Jin-Hou Wu

  • Po-Nan Wang

  • Ming-Chung Kuo

  • Tzung-Chih Tang

Medical Centers

  • Chang Gung University, Taoyuan City, Taiwan

  • College of Medicine, Chang Gung University, Taoyuan, Taiwan

  • Division of Hematology-Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan

  • Division of Hematology/Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • Cluster of Differentiation 177

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved